tiprankstipranks
Hikma Pharmaceuticals PLC (DE:H5P)
FRANKFURT:H5P

Hikma Pharmaceuticals (H5P) Ownership - Who Owns Hikma Pharmaceuticals?

3 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 13, 2024
Susan Ringdal
Vice President
Sold£156328
Mar 13, 2024
Brian Hoffmann
Divisional President
Sold£175914
Mar 07, 2024
Julie Hill
Divisional Vice President
Sold£42212
Aug 10, 2023
Brian Hoffmann
Divisional President
Sold£130360

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
429,690Insider9,367,242
192,394Insider4,194,189
10,000Insider218,000
161,391Insider3,518,324
431,532Insider9,407,398
2,006,299Insider43,737,318
63,952Insider1,394,154
7,100Insider154,780
4,500Insider98,100
1,353,721Insider29,511,118

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
724,338Institution17,078,441
804,549Institution18,969,656
-11,586Institution-273,175
88,240Institution2,080,523
30,541Institution720,096
261,395Institution6,163,171
5,437,941Institution128,215,773
2,000Institution47,156
-935Institution-22,045
64,000Institution1,508,992

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Hikma Pharmaceuticals PLC (DE:H5P)?
Currently, no data Available
What percentage of Hikma Pharmaceuticals PLC (DE:H5P) stock is held by institutional investors?
Currently, no data Available
What percentage of Hikma Pharmaceuticals PLC (DE:H5P) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Hikma Pharmaceuticals PLC (DE:H5P)?
Khalid Nabilsi owns the most shares of Hikma Pharmaceuticals PLC (DE:H5P).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis